Envoy Medical shares are trading higher after the company announced the submission of the first module of its Modular Premarket Approval app
Envoy Medical shares are trading higher after the company announced the submission of the first module of its Modular Premarket Approval application to the FDA for its Breakthrough Device-designated product.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.